Innospec Inc.
NASDAQInnospec reports Q2 results today with a borrowing market that tells an unusual story for a stock where short sellers have largely stayed away. The standout detail in the pre-earnings setup is not the level of short interest — at under 2% of free float, it remains genuinely low — but the pace at which borrowing costs have risen. The cost to borrow has more than tripled over the…
IOSP cost to
Full pulse commentary is for ORTEX subscribers. The live data picture for IOSP below stays open — short interest, options flow, signals, and historical context.
Sign up free to read pulse →Short interest % of float, cost to borrow, utilization, and put/call ratio for IOSP are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 7 Aug 2026
Innospec reports Q2 results today with a borrowing market that tells an unusual story for a stock where short sellers have largely stayed away. The standout detail in the pre-earnings setup is not the level of short…
Innospec reports Q1 2026 results on May 8 with short sellers notably absent and options positioning carrying a persistent defensive tilt. The options picture is the most consistent signal heading into the print. Puts…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IOSP — free to start on ORTEX.
Sign up for free →Open IOSP on ORTEX